Palliative sedation for terminally ill cancer patients at home in Japan：A retrospective analysis
10.2512/jspm.10.141
- VernacularTitle:在宅療養中の終末期がん患者に対する鎮静についての後方視的カルテ調査
- Author:
Takuya Shinjo
;
Akihiro Ishikawa
;
Masahiro Goshima
- Publication Type:Journal Article
- Keywords:
cancer;
palliative sedation;
home care
- From:Palliative Care Research
2015;10(1):141-146
- CountryJapan
- Language:Japanese
-
Abstract:
Some terminally ill cancer patients are treated with palliative sedation（PS）to alleviate their suffering. There have been very few studies in Japan investigating PS in the home. Thus, the aim of the present study was to investigate PS at home for terminally ill patients. A retrospective chart review was performed of 117 cancer patients who died at home between August 2012 and July 2014. Of the 73 who patients died at home, 24（33％）had received PS. The mean duration of PS was 4.4±6.0 days. Patients receiving PS were started on a mean dose of 12.8±6.2 mg/day midazolam；the mean dose at the end of PS was 12.4±6.5 mg/day midazolam. The primary reason for starting PS was delirium（n＝22）. PS in the home was feasible and was an essential treatment for cancer patients at home. We conclude that PS can be used safely and efficaciously to treat terminally ill cancer patients with refractory symptoms in their own home.
